Your browser doesn't support javascript.
loading
Safety and efficacy of an extended-release peptide YY analogue for obesity: A randomized, placebo-controlled, phase 1 trial.
Tan, Tricia M-M; Minnion, James; Khoo, Bernard; Ball, Laura-Jayne; Malviya, Reshma; Day, Emily; Fiorentino, Francesca; Brindley, Charlie; Bush, Jim; Bloom, Stephen R.
Afiliação
  • Tan TM; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
  • Minnion J; Zihipp Ltd, London, UK.
  • Khoo B; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
  • Ball LJ; Zihipp Ltd, London, UK.
  • Malviya R; Division of Medicine, University College London, London, UK.
  • Day E; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
  • Fiorentino F; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
  • Brindley C; Zihipp Ltd, London, UK.
  • Bush J; Imperial Clinical Trials Unit, Imperial College London, London, UK.
  • Bloom SR; Imperial Clinical Trials Unit, Imperial College London, London, UK.
Diabetes Obes Metab ; 23(7): 1471-1483, 2021 07.
Article em En | MEDLINE | ID: mdl-33606914
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeo YY / Obesidade Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeo YY / Obesidade Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article